EP1 prostanoid receptor antagonists (Affectis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEP1 prostanoid receptor antagonists (Affectis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E2 inhibitors
TargetsProstaglandin E2
Therapy Area/IndicationsDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffectis Pharmaceuticals Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffectis Pharmaceuticals Ag
Active IndicationsN/A
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A